Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy
2011

Nephropathy in SIV-Infected Macaques During Antiretroviral Therapy

Sample size: 33 publication 10 minutes Evidence: moderate

Author Information

Author(s): Brigitte E Sanders-Beer, Yvette Y Spano, Dawn Golightly, Abigail Lara, Diane Hebblewaite, Lourdes Nieves-Duran, Lowrey Rhodes, Keith G Mansfield

Primary Institution: Southern Research Institute

Hypothesis

What are the clinical and biochemical correlates of nephropathy in SIV-infected macaques receiving high-dose antiretroviral therapy?

Conclusion

The study found that morphologic evidence of nephropathy was common in SIV-infected macaques receiving high-dose ART, but acute renal failure was rare.

Supporting Evidence

  • Acute renal failure was uncommon, occurring in only 7.1% of treated animals.
  • Morphologic evidence of nephropathy persisted for more than 300 days after treatment.
  • Biochemical changes in BUN and phosphorus correlated with disease severity.

Takeaway

When macaques with SIV were treated with high doses of certain medications, many showed signs of kidney problems, but very few had serious kidney failure.

Methodology

The study involved administering high-dose ART to SIV-infected macaques and monitoring their health through biochemical and histological evaluations.

Potential Biases

Potential bias may arise from the specific selection of macaques and the treatment regimen used.

Limitations

The study was limited by the small sample size and the inability to predict acute renal failure based on serum chemistry values.

Participant Demographics

All participants were male Indian-origin rhesus macaques.

Statistical Information

P-Value

0.0008

Confidence Interval

95% CI -0.7964 to -0.1079

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-6405-8-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication